Zetia and Osteoporosis - a phase IV clinical study of FDA data
Osteoporosis is found among people who take Zetia, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Zetia and have Osteoporosis. It is created by eHealthMe based on reports of 43,967 people who have side effects when taking Zetia from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
43,967 people reported to have side effects when taking Zetia.
Among them, 261 people (0.59%) have Osteoporosis.
What is Zetia?
Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 45,136 Zetia users for its effectiveness, alternative drugs and more.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,360 drugs and 1,804 conditions by eHealthMe.
Number of Zetia and Osteoporosis reports submitted per year:
Time on Zetia when people have Osteoporosis *:
Gender of people who have Osteoporosis when taking Zetia*:
Age of people who have Osteoporosis when taking Zetia *:
Common drugs people take besides Zetia *:
Common side effects people have besides Osteoporosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zetia and have Osteoporosis?Check whether Osteoporosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Alternative drugs to, pros and cons of Zetia:
- Zetia (45,136 reports)
Osteoporosis treatments and more:
- Osteoporosis (254,707 reports)
COVID vaccines that are related to Osteoporosis:
- Osteoporosis in Moderna COVID Vaccine
- Osteoporosis in Pfizer BioNTech Covid Vaccine
- Osteoporosis in Johnson and Johnson Covid Vaccine
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of ezetimibe:
- Osteoporosis and drugs with ingredients of ezetimibe (266 reports)
Common drugs associated with Osteoporosis:
All the drugs that are associated with Osteoporosis:
- Osteoporosis (2,360 drugs)
Common conditions associated with Osteoporosis:
All the conditions that are associated with Osteoporosis:
- Osteoporosis (1,804 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.